Companies / BP8

BPH GLOBAL LTD

ASX:BP8Pharmaceuticals, Biotechnology & Life Sciences
2.35B shares on issueASX (delayed) · as of 28 July 2026$0.002price · delayed$4.7Mmarket cap · indicative
F
Dilution grade

Runway under 2 quarters; share count grew 493% in 24 months; 8 cash raises in 24 months

Cash runway-0.4 quarters of funding
Share-count growth (24m)493.4%
Raise cadence (24m)8 cash raises
Options & rights overhang44.2% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

BPH GLOBAL LTD's ordinary share count grew 493.4% between June 2024 and February 2026 to 2.35B shares. The company raised capital eight times in the 24-month window for total disclosed proceeds of A$3.4M, most recently reporting A$1.0M in February 2026. Options and rights on issue could convert into 1.04B new shares, equal to 44.2% of the current share count, with no in‑the‑money portion and the nearest expiry in December 2026. At the March 2026 quarter the company reported A$-293K in available cash, equal to -0.4 quarters of cover. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
44.2%
Max option dilution
0.0%
ITM option dilution
2
Raises · last 12 months
-0.4 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 2.35B per ASX (delayed) (28 July 2026).
0.81B1.38B1.94BDec 24Sept 25July 26Cash raise · 2 Feb 2026Cash raise · 12 Sept 2025Cash raise · 22 Apr 2025Cash raise · 8 Apr 2025Cash raise · 26 Feb 2025Cash raise · 17 Dec 2024Cash raise · 11 Dec 2024

Cash runway

-0.4 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
$-293k available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
16 Apr 20263H · cancellationBP8 : ORDINARY FULLY PAID2.35BAppendix 3H
13 Feb 20262A · quoted issueBP8 : ORDINARY FULLY PAID2.35BAppendix 2A
24 Dec 20253H · cancellationBP8 : ORDINARY FULLY PAID1.85BAppendix 3H
16 Dec 20253G · unquotedORDINARY FULLY PAID1.85BAppendix 3G
11 Dec 20253G · unquotedBP8 : ORDINARY FULLY PAID1.85BAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

8 cash raises in the last 24 months · 2 in the last 12 months

$1.0M
Capital raise
2 Feb 2026
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

44.2%
Total overhang · of current shares
0.0%
In the money · at current price
1.04B
Potential new shares
Dec 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
4 Dec 2025Deepak JhaOther———3Y notice
27 Nov 2025Matthew LeonardOther121.2M833k—3Y notice
27 Nov 2025Paul StephensonOther107.2M833k—3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

22 July 2026Direct commercial shipment of seaweed to China completed
16 July 2026Becoming a substantial holder
12 July 2026$PSeaweed Trading Results - Direct China Exports Commence
7 July 2026BPH Global commences direct seaweed exports to China
22 June 2026Final Director's Interest Notice
21 June 2026Resignation / Appointment of Chairman
11 June 2026Investor Presentation
27 May 2026$PStrong seaweed trading results A$3.33M over first 12 months
27 May 2026Becoming a substantial holder
11 May 2026Agreement to Develop Powdered Green Seaweed Kefir Additive
7 May 2026Update to Quarterly Activities Report
6 May 2026$PTesting Agreement Executed for Project Giddy-Up
5 May 2026$PBinding MoU to Progress Development of Makassar Coastal Site
30 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
27 Apr 2026$PTrading Results Rebound as Seasonal Conditions Improve
26 Apr 2026Appointment of Chief Scientific Officer
24 Apr 2026Sale of China Birds Nest Business
22 Apr 2026$PDevelopment of Seaweed-based anti-aging supplement
21 Apr 2026$PBPH Global Secures Coastal Site for Seaweed Cultivation
19 Apr 2026BPH Global Launches New Investor Hub

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.